Botanical preparations
Reviewed November 2026
Research strength — Moderate for specific standardised extracts (St. John's wort in mild-to-moderate depression, oral lavender oil in anxiety), Preliminary for ashwagandha, chamomile and valerian.
Traditional convergence — Very strong (systematic botanical classifications weighing benefit against toxicity appear independently across Ayurvedic, Chinese and Greco-Roman traditions for two millennia).
In short: plants are pharmacology, not gentle background tea — and the evidence varies sharply by species and extract. A Cochrane review of 29 trials found standardised St. John's wort outperformed placebo and matched standard antidepressants in mild-to-moderate depression,1 while a standardised oral lavender oil (Silexan) lowered anxiety scores across five placebo-controlled trials.2 By contrast, valerian has failed to improve objective sleep measures across eight systematic reviews,3 and ashwagandha's large pooled anxiety numbers come with low certainty and extreme trial inconsistency.4 Because plant extracts alter liver enzymes, hormones and brain chemistry, "natural" does not mean harmless: St. John's wort causes dangerous medication interactions,5 and ashwagandha carries rare reports of acute liver injury.6
What it is
Using dried herbs, teas, tinctures or standardised plant extracts to influence mood, anxiety, stress response or sleep.
Unlike breathwork or attention practices, botanicals act chemically — through active compounds that bind neurotransmitter receptors, alter cortisol output or speed up liver drug metabolism.5 Two bottles carrying the same plant name on the label can contain wildly different doses of active compounds depending on plant part, harvest, extraction method and shelf life.7
What it does for you
St. John's wort matches standard antidepressants in mild-to-moderate depression
A Cochrane systematic review of 29 double-blind randomised trials (5,489 patients with major depression) found that standardised Hypericum perforatum extracts beat placebo in nine larger trials (response rate ratio 1.28, 95% CI [1.10, 1.49]) and nine smaller trials (RR = 1.87, 95% CI [1.22, 2.87]).1
Compared head-to-head against synthetic antidepressants, response rates were virtually identical — RR = 1.02 against tricyclic antidepressants and RR = 1.00 against selective serotonin reuptake inhibitors (SSRIs) — with fewer patients dropping out due to side effects.1 International psychiatric taskforce guidelines support it for unipolar depression, provided medication interactions are ruled out.8
Standardised oral lavender oil reduces anxiety symptoms
A 2023 meta-analysis of 5 randomised placebo-controlled trials of Silexan (80 mg/day oral Lavandula angustifolia oil over 10 weeks) in subthreshold and generalised anxiety found an average 2.9-point advantage on the Hamilton Anxiety Rating Scale over placebo (SMD = 0.35, 95% CI [0.13, 0.56], p = 0.002), with a responder rate ratio of 1.34.2 Both psychic and somatic anxiety subscores improved.2
Chamomile improves subjective sleep quality slightly
Across 10 clinical trials (772 participants), a 2024 meta-analysis pooling five trials found oral chamomile (Matricaria chamomilla) lowered subjective Pittsburgh Sleep Quality Index scores (WMD = −1.88, 95% CI [−3.46, −0.31]), with benefits clustered around falling asleep and fewer night awakenings.9 Sleep duration, daytime functioning and objective sleep measures did not improve.9
Ashwagandha lowers perceived stress and anxiety — with low certainty
A meta-analysis of 12 randomised trials (1,002 adults) found that ashwagandha (Withania somnifera) reduced anxiety (SMD = −1.55, 95% CI [−2.37, −0.74]) and perceived stress (SMD = −1.75, 95% CI [−2.29, −1.22]) over placebo, with stress reductions clustered around 300 to 600 mg per day.4 However, the authors graded the certainty of evidence as low for both outcomes, and statistical inconsistency across trials was extreme (I² = 93.8% for anxiety; 83.1% for stress).4
Psychiatric guideline snapshot
Because "herbal remedies" are too diverse to grade as one category, international clinical guidelines (WFSBP and CANMAT) separate them strictly by plant and condition:8
| Botanical | Guideline assessment |
|---|---|
| St. John's wort | Supported for mild-to-moderate unipolar depression (high interaction risk) |
| Oral lavender oil (Silexan) & Ashwagandha | Modestly supported for anxiety symptoms |
| Chamomile & Kava | Not recommended for generalised anxiety disorder |
| Rhodiola | Not supported for mood disorders |
How much you need to do
- Standardised extract matters more than raw powder. Clinical results belong to the specific tested extract and dose — such as 80 mg/day of pharmaceutical-grade oral lavender oil for 10 weeks,2 or 300–600 mg/day of standardised ashwagandha root extract for 8 weeks.4
- Herbal teas are gentler and harder to dose. Evening infusions such as chamomile can serve as a pleasant, low-risk wind-down cue, yet trial doses vary widely between capsules, extracts and teas.9
- Stop and reassess after 4 to 8 weeks. Unlike practice-based skills, continuing an ineffective botanical carries ongoing cost and physiological exposure without compounding skill gains.
So: treat any botanical extract like a mild medication — match the exact tested extract and dose, run a bounded four-to-eight-week check against a specific symptom, and verify interactions with a pharmacist first.
Practices that rest on it
Where the evidence stops
Valerian fails objective sleep tests. Although a 2020 review pooling 10 subjective studies (1,065 participants) noted improved sleep-quality ratings alongside unstable plant chemistry,7 a 2024 umbrella review of eight systematic reviews concluded valerian lacks empirical support for insomnia: studies are scarce, inconsistent and low quality, with no benefit on objective sleep architecture.3
Commercial bias sits heavy on the best-looking trials. In the five-trial lavender oil meta-analysis, trials were linked with the product manufacturer (Schwabe), and key authors held financial or consulting ties.2 Similarly, many positive ashwagandha trials are small, single-region studies funded by extract suppliers, producing implausibly large effect sizes alongside 90%+ heterogeneity.4
Quality control in retail supplements is weak. Unstable active compounds break down during storage,7 and commercial multi-ingredient capsules frequently suffer from mislabelling, variable potency or undeclared adulterants.10
Unknowns: long-term safety and efficacy beyond two to three months for nearly all calming herbs; whether combining whole-herb teas adds anything beyond the warm evening ritual itself;9 and how root-only extracts compare against leaf-containing supplements on side-effect risk.10
And one thing to actively disbelieve: that "natural" or "plant-based" implies gentle, harmless or free of drug interactions. Plants evolve biologically active molecules precisely to affect physiology — and several widely sold herbs match prescription drugs in their power to interfere with other treatments.5
Who should be careful
Prescription medication interactions — especially St. John's wort. St. John's wort strongly induces liver enzymes (CYP3A4 and others) and drug-transport proteins (P-glycoprotein), accelerating the breakdown of prescribed drugs.5 It has documented clinically serious drops in blood levels of cyclosporine and tacrolimus (causing transplant rejection), warfarin, digoxin, HIV medications, chemotherapy agents and oral contraceptives (causing breakthrough bleeding and unintended pregnancy).5 Combined with SSRIs or other antidepressants, it can trigger dangerous serotonin syndrome.5 Never start or stop St. John's wort alongside prescription medication without checking with a doctor or pharmacist.
Rare liver injury from ashwagandha and kava. Case series from Iceland and the US Drug-Induced Liver Injury Network have documented acute cholestatic and mixed liver injury linked to ashwagandha supplements,6 and the US National Institutes of Health LiverTox database classifies ashwagandha as a probable cause of rare, idiosyncratic liver injury.10 Kava carries similar hepatotoxicity warnings and is restricted or unrecommended in clinical guidelines.8 Stop immediately and seek medical care if jaundice, dark urine, severe itching or upper-right abdominal pain appears.6
Drowsiness and sedatives. Valerian and calming extracts can cause morning grogginess and should not be combined with alcohol, benzodiazepines or sedative sleep medications, or taken before driving if drowsiness occurs.7
Pregnancy, breastfeeding, thyroid and hormone-sensitive conditions. As a clinical and practical judgement: because herbal extracts cross biological barriers, vary in purity and can alter thyroid or steroid hormones, avoid unprescribed concentrated botanical capsules during pregnancy, breastfeeding, autoimmune disease, thyroid disorders or liver disease.
Traditional convergence
Very strong. Long before clinical pharmacology, the major medical traditions independently learned that plants sit on a spectrum from nourishing foods to potent poisons — and organised whole compendia to separate safe daily herbs from targeted medicines.
In India, the Caraka Saṃhitā opens its section on treatment with rasāyana preparations — including plants classified as medhya for memory and steadiness of mind — specifying preparation, dose and user condition carefully.11 In China, the Shennong Bencao Jing (Divine Farmer's Materia Medica) classifies 365 substances into three grades: mild upper-grade herbs suited to regular tonic use without toxicity, middle-grade herbs whose dose and context require caution, and lower-grade agents reserved strictly for acute disease because of toxicity.11 And in the Mediterranean, Pedanius Dioscorides' De Materia Medica systematically recorded roughly 500 plants across five books, detailing preparation, dosage, storage and adverse effects from direct observation.11
If you want to test a simple, low-risk baseline without buying capsules, drink a single plain herbal infusion such as chamomile tea in the evening for two weeks while keeping caffeine and screen timing constant, and observe whether it changes anything beyond the quiet pause of making a warm drink.
References
APA 7th.
Footnotes
-
Linde, K., Berner, M. M., & Kriston, L. (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews, (4), CD000448. https://doi.org/10.1002/14651858.CD000448.pub3 ↩ ↩2 ↩3
-
Dold, M., Bartova, L., Volz, H.-P., Seifritz, E., Möller, H.-J., Schläfke, S., & Kasper, S. (2023). Efficacy of Silexan in patients with anxiety disorders: A meta-analysis of randomized, placebo-controlled trials. European Archives of Psychiatry and Clinical Neuroscience, 273(7), 1615–1628. https://doi.org/10.1007/s00406-022-01547-w ↩ ↩2 ↩3 ↩4 ↩5
-
Valente, V., Machado, D., Jorge, S., Drake, C. L., & Marques, D. R. (2024). Does valerian work for insomnia? An umbrella review of the evidence. European Neuropsychopharmacology, 82, 6–28. https://doi.org/10.1016/j.euroneuro.2024.01.008 ↩ ↩2
-
Akhgarjand, C., Asoudeh, F., Bagheri, A., Kalantar, Z., Vahabi, Z., Shab-Bidar, S., Rezvani, H., & Djafarian, K. (2022). Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 36(11), 4115–4124. https://doi.org/10.1002/ptr.7598 ↩ ↩2 ↩3 ↩4 ↩5
-
Borrelli, F., & Izzo, A. A. (2009). Herb–drug interactions with St John's wort (Hypericum perforatum): An update on clinical observations. The AAPS Journal, 11(4), 710–727. https://doi.org/10.1208/s12248-009-9146-8 ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Björnsson, H. K., Björnsson, E. S., Avula, B., et al. (2020). Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 40(4), 825–829. https://doi.org/10.1111/liv.14393 ↩ ↩2 ↩3
-
Shinjyo, N., Waddell, G., & Green, J. (2020). Valerian root in treating sleep problems and associated disorders—A systematic review and meta-analysis. Journal of Evidence-Based Integrative Medicine, 25, 2515690X20967323. https://doi.org/10.1177/2515690X20967323 ↩ ↩2 ↩3 ↩4
-
Sarris, J., Ravindran, A., Yatham, L. N., Marx, W., Rucklidge, J. J., McIntyre, R. S., et al. (2022). Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The World Journal of Biological Psychiatry, 23(6), 424–455. https://doi.org/10.1080/15622975.2021.2013041 ↩ ↩2 ↩3
-
Kazemi, A., Shojaei-Zarghani, S., Eskandarzadeh, P., & Hashempur, M. H. (2024). Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine, 84, 103071. https://doi.org/10.1016/j.ctim.2024.103071 ↩ ↩2 ↩3 ↩4
-
National Institute of Diabetes and Digestive and Kidney Diseases. (2019). Ashwagandha. In LiverTox: Clinical and research information on drug-induced liver injury. National Institutes of Health. https://www.ncbi.nlm.nih.gov/books/NBK548536/ ↩ ↩2 ↩3
-
Caraka Saṃhitā, Cikitsāsthāna, ch. 1 (Rasāyana, including medhya rasāyana preparations); Shennong Bencao Jing (Divine Farmer's Materia Medica, classifying 365 substances across upper, middle and lower grades); Pedanius Dioscorides, De Materia Medica, Books I–V. ↩ ↩2 ↩3